Texas Heart Institute
Avatar

Silent Leaflet Thrombosis After TAVR: Is Absence of Anticoagulation Therapy the Main Cause of SLT? How to Treat it?

By Texas Heart Institute FEATURING Zvonimir Krajcer
March 18, 2021
1 Comment
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Boston Scientific
Lifetime Management and Cerebral Embolic Protection in TAVR
Thu, Apr 14, 2022
Faculty: Boston Scientific , Kendra Grubb , Thomas Waggoner
11:19
Houston Methodist DeBakey Heart and Vascular Center

TAVR for Stenosis: Is it for Every Patient?

Feat. M. Reardon
06:14
Scottsdale Interventional Forum 2021

Tips for Accessing the Coronaries After TAVR: Should You Consider Do…

Feat. N. Sutton
36:11
ARCH Advanced Revascularization Symposium

The UPSTREAM Management of Aortic Stenosis in the Future

Feat. M. Leon
20:21
2017 Recent Advances in the Management of Valvular Heart Disease

Management of AV Block after TAVR

Feat. M. Faddis
17:43
New York Transcatheter Valves 2020

TAVR Antithrombotics Update: What Is Clopidogrel Loading Associated …

Feat. G. Dangas
19:18
San Diego Cardiovascular Interventions (SDCI) 2018

Antiplatelet Therapy or Anticoagulation after TAVR

Feat. O. Ben-Yehuda
13:04
ARCH Advanced Revascularization Symposium

TAVR Deployment: Non-Coronary Isolation & Cusp Overlap

Feat. N. L. Frogge
06:13
Scottsdale Interventional Forum 2021

RECOVERY, POPular TAVI & Solve-TAVI Trials: Is There a Lower Ris…

Feat. D. Rizik
10:41
New York Transcatheter Valves 2021

Pharmacology in TAVR: State of the Art

Feat. G. Dangas
20:46
David Rizik

Top Ten Trials of 2020 – 2021 in Coronary and Structural Cardiology:…

27:42
Cardiovascular Disease Management - 5th Annual Symposium

TAVR is Here and Mainstream: With the Risk of Stroke During Any Valv…

Feat. J. Carroll
33:59
New York Transcatheter Valves 2021

Top Ten Advances in Transcatheter Valve Therapy 2021

Feat. S. Sharma
19:38
Jeremy Ruskin

Atrial Fibrillation Management in a Patient Post Aortic Valve Replac…

Feat. P. Kowey, E. Prystowsky
34:40
ARCH Advanced Revascularization Symposium

Management of CAD and Aortic Stenosis: Current Thought on the Low-Ri…

Feat. M. Sintek
31:12
New York Transcatheter Valves 2020

Top Advances in TAVR: Anticoagulation Post TAVR, Procedures & Ou…

Feat. S. Sharma
14:38
Scottsdale Interventional Forum 2022

Critical Decision-Making in Valvular Heart Disease Management: Hemod…

Feat. J. Lasala
02:40
Northwestern Medicine Cardiovascular Care

Advances in Transcatheter Heart Valve Offerings

Feat. C. Davidson
23:34
Scottsdale Interventional Forum 2021

Severe Bicuspid AS in the Setting of Cardiogenic Shock: Case Present…

Feat. D. Rizik
11:33
American Heart & Vascular Institute

TAVR and Anti-Platelets: Single, Dual or Triple Therapy?

Feat. M. Ansari
12:30
Scottsdale Interventional Forum 2018

PPM and Conduction Disease Post TAVR

Feat. M. Rinaldi